Document:

Form of Lock-up Agreement

 Exhibit 4.3 
 Lock-Up Agreement 
 Actions Semiconductor Co., Ltd. 
 July 12, 2006 
 MORGAN STANLEY & CO. INTERNATIONAL LIMITED

     25 Cabot Square 
     Canary Wharf 
     London E14 4QA 
     United Kingdom 
     and 
 CITIGROUP GLOBAL MARKETS INC. 
     388 Greenwich Street

     New York, NY 10013 
     United States 
 (as Representatives of the Underwriters) 
 ACTIONS SEMICONDUCTOR CO., LTD. 
     15-1, No.1 HIT Road 
     Tangjia, Zhuhai 
     Guangdong,
519085 
     The People’s Republic of China 
 Dear Sirs: 
 As an inducement to the Underwriters (defined herein) to execute the underwriting agreement (the “Underwriting
Agreement”) among Actions Semiconductor Co., Ltd. (“Actions”), the selling shareholders named therein, and Morgan Stanley & Co. International Limited and Citigroup Global Markets Inc., acting as representative s (the
“Representatives”) of the underwriters (the “Underwriters”) named therein, pursuant to which an offering will be made that is intended to result in the establishment of a public market for Ordinary Shares, par value
U.S.$0.000001 per share (the “Securities”) of Actions, and any successor (by merger or otherwise) thereto, (the “Company”), the undersigned hereby agrees that during the period specified in the following paragraph
(the “Lock-Up Period”), the undersigned will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any shares of Securities or securities convertible into or exchangeable or exercisable for any
shares of Securities, enter into a transaction which would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of the Securities, whether any
such aforementioned transaction is to be settled by delivery of the Securities or such other securities, in cash or otherwise, or publicly disclose the intention to make any such offer, sale, pledge or disposition, or to enter into any such
transaction, swap, hedge or other arrangement, without, in each case, the prior written consent of the Representatives. In addition, the undersigned agrees that, without the prior written consent of the Representatives, it will not, during the
Lock-Up Period, make any demand for or exercise any right with respect to, the registration of any Securities or any security convertible into or exercisable or exchangeable for the Securities. 
 The initial Lock-Up Period will commence on the date of this Lock-Up Agreement and continue and include the date 90 days after the public offering date
set forth on the final prospectus used to sell the Securities (the “Public Offering Date”) pursuant to the Underwriting Agreement; provided, however, that if (1) during the last 17 days of the initial Lock-Up Period, the Company
releases earnings results or material news or a material event relating to the Company occurs or (2) prior to the expiration of the initial Lock-Up Period, the Company announces that it will release earnings results during the 16-day period
beginning on the last day of the initial Lock-Up Period, then in each case the Lock-Up Period will be extended until the expiration of the 18-day period beginning on the date of release of the earnings results or the occurrence of the material news
or material event, as applicable, unless the Representatives waives, in writing, such extension. 

 The undersigned hereby acknowledges and agrees that written notice of any extension of the Lock-Up Period
pursuant to the previous paragraph will be delivered by the Representatives to the Company and that any such notice properly delivered will be deemed to have given to, and received by, the undersigned. The undersigned further agrees that, prior to
engaging in any transaction or taking any other action that is subject to the terms of this Lock-Up Agreement during the period from the date of this Lock-Up Agreement to and including the 34th day following the expiration of the initial Lock-Up
Period, it will give notice thereof to the Company and will not consummate such transaction or take any such action unless it has received written confirmation from the Company that the Lock-Up Period (as may have been extended pursuant to the
previous paragraph) has expired. 
 Any Securities received upon exercise of options granted to the undersigned will also be subject to this
Agreement. Any Securities acquired by the undersigned in the open market will not be subject to this Agreement. A transfer of Securities to a family member or trust may be made, provided the transferee agrees to be bound in writing by the terms of
this Agreement prior to such transfer and no filing by any party (donor, donee, transferor or transferee) under the Securities Exchange Act of 1934 shall be required or shall be voluntarily made in connection with such transfer (other than a filing
on a Form 5 made after the expiration of the Lock-Up Period). 
 In furtherance of the foregoing, the Company and its transfer agent and
registrar are hereby authorized to decline to make any transfer of shares of Securities if such transfer would constitute a violation or breach of this Agreement. 
 This Agreement shall be binding on the undersigned and the successors, heirs, personal representatives and assigns of the undersigned. This Agreement shall lapse and become null and void if the Public Offering Date
shall not have occurred on or before October 17, 2006. This agreement shall be governed by, and construed in accordance with, the laws of the State of New York. 
  

			
		 	Very truly yours,
		
		 	  
		 	 Name:
 Title:
 CompanyExecutive Employment Agreement

 Exhibit 10.1 
 Executive Employment Agreement 
 July 25, 2006 
 Mr. Edward Calnan 
 8 Winslow Square Lane 
 Marblehead, MA 01945 
 Dear Mr. Calnan, 
 Employment: I am pleased to confirm your offer of employment with Document Sciences Corporation (“the Company”) in the capacity Senior Vice President, Sales reporting to Jack McGannon, President and Chief Executive
Officer. You will be based out of your home office, but will periodically be required to travel to other geographic locations in connection with performance of your duties. Your proposed start date is September 16, 2006. 
 Compensation: The goals of our executive compensation program are to align compensation with business objectives and performance against those objectives.
Pay is sufficiently variable such that above-average performance results in above-target total compensation. 
 We use a total compensation program, which
consists of both cash and equity-based compensation, and has three components. The three components are intended to attract, retain, motivate and reward executives who contribute to our long-term success. The three components are: 
  

	 	•	 	Base Salary: Our offer is a base salary of $200,000, which reflects salary surveys of a leading national compensation consultant. Base salary increases are made based on an
annual review of contributions to the company. 

  

	 	•	 	Variable Compensation: Variable compensation for the SVP, Sales position is targeted at 100% of base salary for on-plan performance. Our variable compensation formula incents
above-plan performance with compensation accelerators, allowing the SVP, Sales to achieve levels above 100% of base salary. Your specific plan will be outlined in an Annual Sales Objective Agreement. 

  

	 	•	 	Long-Term Incentives: Long-term incentives are provided through grants of stock options and restricted stock. By accepting our offer, you will receive 25,000 restricted
shares of Document Sciences Corporation common stock (subject to state and federal regulations and upon approval by the board of directors at their next regularly scheduled meeting following your start date). The restricted shares will vest over 3
years according to the following schedule: 30% vested at the end of one year, next 30% vested at the end of two years, and the final 40% vested at the end of three years. You will also receive options to purchase 25,000 shares of Document Sciences
Corporation common stock (subject to state and federal regulations and upon approval by the board of directors at their next regularly scheduled meeting following your start date). The stock options will vest over three years according to the
following schedule: 30% vested at the end of one year, the remaining 70% vested ratably over the next 24 months. 

 Benefits: You
will begin to accrue paid vacation leave each pay period, equaling eighteen days over a one-year period. In addition, you will receive two Personal Choice days and five Sick days (pro-rated based on your date of hire) that may be used each year as
stated in our established policies and procedures. You will also qualify to participate in the Company’s health, dental, life, disability and 401(k) benefit plans, subject to the terms, conditions and limitations contained in the applicable
plan documents and insurance policies. 
 Drug Screening: In accordance with our standard policy, this offer is subject to reference checks and
your successful completion of a drug-screening test prior to your proposed start date. You will be contacted immediately following receipt of your signed acceptance of this offer of employment to arrange for testing. 

 Condition of Employment: Employment with Document Sciences Corporation is at the mutual consent of each
employee and the Company. Accordingly, employees and Document Sciences Corporation retain that right to terminate the employment relationship at will, at any time, with or without cause. Please note that no individual, other than the
President & CEO of Document Sciences Corporation, has the authority to make any contrary agreement or representation in writing signed by the President & CEO. Therefore, this constitutes a final and fully binding integrated
agreement with respect to the at-will nature of the employment relationship. Please note that Document Sciences Corporation strictly abides by all immigration and employment laws. Therefore, this offer of employment is subject to compliance with
U.S. Immigration Law. 
 Non-competition: During employment and for a period of six months from your termination, you agree that you will not
be employed by any competitor of Document Sciences (i.e. a business that provides the same or substantially similar products and services as those provided by Document Sciences, including but not limited to the following competitors and their
affiliates – Exstream Software, Docucorp, Group 1 Software, InSystems, GMC Software, Thunderhead, XMPie Inc. and ISIS) in a similar job position as that which you last held at Document Sciences. Moreover, the non-compete covenant will not apply
in the case of a change of control of the company. 
 Termination without Cause: The Company may terminate your employment without Cause by
giving written notice to you. In such an event, provided that you sign and comply with a release of claims in a form acceptable to the Company, the Company will pay you your then-current base salary for a six-month period as well as any bonuses
earned and accrued through the termination date payable in accordance with the Company’s normal payroll procedures and policies. Additionally, you will receive continuation of health benefits for six months. 
 As used herein, Cause shall mean: 
  

	 	a)	An act of willful dishonesty taken in connection with your responsibilities as an employee and causing damage to the Company; 

  

	 	b)	Your commission of, or plea of nolo contender to, a felony; 

  

	 	c)	Your insubordination or willful refusal to follow reasonable directives of the Board of Directors; 

  

	 	d)	Your violation of the Confidentiality Agreement between yourself and the Company; and 

  

	 	e)	Your gross negligence or willful misconduct in the performance of his duties as an employee of the Company. 

 Restrictive Covenants: Your employment with the Company is contingent upon the fact that you will not be limited in performing your duties with the Company
due to conditions of an employment agreement (including but not limited to restrictive covenants) with a previous employer that remain in effect during your employment with the Company. 
 On behalf of our entire Document Sciences team, I look forward to your acceptance of this offer. Please indicate your acceptance and agreement with the terms of this offer in all respects by signing and returning this
letter. A favor of reply is requested within five working days of this letter date, after which time this offer is considered void. If you have any questions, please call me at 760/602-1411 or you may contact Thanos Karavoikiris, our Director of
Finance, at 760/602-1413. 
  

					
	 Best Regards,
	 		 	 AGREED AND ACCEPTED:

			
	 /s/ J.L. McGannon
	 		 	 /s/ Edward Calnan

	 John L. McGannon
	 		 	 Edward Calnan

	 President and Chief Executive Officer
	 		 	
	 Document Sciences Corporation
	 		 	 7-27-06

		 		 	 Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]